1. Home
  2. LONA vs ICG Comparison

LONA vs ICG Comparison

Compare LONA & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$6.95

Market Cap

71.2M

Sector

Health Care

ML Signal

N/A

Logo Intchains Group Limited

ICG

Intchains Group Limited

N/A

Current Price

$0.95

Market Cap

59.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
LONA
ICG
Founded
2011
2017
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
71.2M
59.7M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
LONA
ICG
Price
$6.95
$0.95
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$10.00
$5.25
AVG Volume (30 Days)
40.2K
140.3K
Earning Date
05-08-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.80
Revenue Growth
N/A
N/A
52 Week Low
$4.21
$0.60
52 Week High
$14.21
$2.28

Technical Indicators

Market Signals
Indicator
LONA
ICG
Relative Strength Index (RSI) 44.48 52.88
Support Level $6.86 $0.63
Resistance Level $8.57 $1.04
Average True Range (ATR) 0.58 0.06
MACD -0.05 -0.01
Stochastic Oscillator 29.70 46.33

Price Performance

Historical Comparison
LONA
ICG

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

About ICG Intchains Group Limited

Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

Share on Social Networks: